Finance

Lists
182400:KOSDAQ
NKGen Biotech Korea Co ltd
-100.00%
(-3,670.00) 1D
Sep 11, 6:16:37 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 182400...
Mkt. cap
172.75B
Volume
0.00
52-wk high
â‚©9,904
52-wk low
â‚©8,621
EPS
-â‚©58
Shares outstanding
72.34M
No. of employees
64
Mkt. cap
172.75B
Volume
0.00
52-wk high
â‚©9,904
52-wk low
â‚©8,621
EPS
-â‚©58
Shares outstanding
72.34M
No. of employees
64
About NKGen Biotech Korea Co ltd
CEO-
Employees64
Founded2002
Headquarters-
SectorBiotechnology
Websitenkmax.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.21B
2.21B
1.57B
2.14B
Cost of goods sold
391.88M
578.36M
241.90M
410.63M
Cost of revenue
391.88M
578.36M
241.90M
410.63M
Research and development expenses
642.10M
454.60M
472.72M
358.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.23B
2.29B
1.33B
1.19B
Operating expense
1.86B
4.57B
2.22B
1.86B
Total operating expenses
2.25B
5.15B
2.46B
2.27B
Operating income
-48.73M
-2.93B
-890.12M
-129.89M
Other non operating income
355.34M
-619.47M
-145.46K
3.31M
EBT including unusual items
215.79M
-782.85M
-592.63M
-176.78M
EBT excluding unusual items
509.09M
-3.68B
-626.82M
-142.96M
Income tax expense
-
-
-27.79M
13.90M
Effective tax rate
-
-
4.69%
-7.86%
Other operating expenses
43.89M
41.92M
58.49M
40.23M
Net income
215.79M
-782.85M
-564.84M
-190.68M
Net profit margin
9.78%
-35.41%
-35.87%
-8.92%
Earnings per share
-
-
-
-
Interest and investment income
162.88M
-
27.58M
16.91M
Interest expense
-19.64M
-84.93M
-120.33M
-119.12M
Net interest expenses
143.24M
-84.93M
-92.75M
-102.21M
Depreciation and amortization charges
42.78M
79.26M
200.33M
251.59M
EBITDA
8.66M
-2.84B
-675.04M
136.48M
Gain or loss from assets sale
-106.27M
106.27M
-
-369.97M
AI content may include mistakes. Learn more
Google apps